Description

Metotrexat-Teva: Solution for Injections 25 mg/ml, 2 ml, №1 Vial

The dosage of Metotrexat-Teva should be individualized based on the patient’s condition and response to treatment. It is usually administered once a week.

Metotrexat-Teva is indicated for the treatment of various types of cancer, rheumatoid arthritis, and psoriasis.

Avoid using Metotrexat-Teva if pregnant, breastfeeding, have liver or kidney disease, or a weakened immune system.

Metotrexat-Teva is administered by injection under the supervision of a healthcare professional. Follow all instructions carefully.

Studies have shown that Methotrexate, the active ingredient in Metotrexat-Teva, is effective in treating various types of cancer by inhibiting the growth of cancer cells. It is also a first-line treatment for rheumatoid arthritis due to its anti-inflammatory properties.
Research published in the Journal of Clinical Oncology demonstrated the efficacy of Methotrexate in combination therapy for certain types of lymphoma, improving overall survival rates in patients.

Metotrexat-Teva is a potent medication that requires careful monitoring during treatment to prevent potential side effects. Regular blood tests are necessary to monitor liver function and blood cell counts.
Discuss any existing medical conditions or medications with your healthcare provider before starting Metotrexat-Teva to avoid potential drug interactions.